• 1
    Engel Jr. Surgical treatment of the epilepsies. 2nd ed. New York: Raven Press, 1993.
  • 2
    Turski WA, Cavalheiro EA, Bortolotto ZA, et al. Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res 1984;321:23753.
  • 3
    Cavalheiro EA, Leite JP, Bortolotto ZA, et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia 1991;32:77882.
  • 4
    Croiset G, Wied D. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system. Brain Res 1997;759:1823.
  • 5
    Croiset G, De Wied D. ACTH: a structure-activity study on pilocarpine-induced epilepsy. Eur J Pharmacol 1992; 229:2116.
  • 6
    Millan HM, Chapman AG, Meldrum, BS. Extracellular amino acid levels in hippocampus during pilocarpine-induced seizures. Epilepsy Res 1993;14:1398.
  • 7
    Smolders I, Khan GM, Lindekens H, et al. Effectiveness of vigabatrin against focally evoked pilocarpine-induced seizures and concomitant changes in extracellular hippocampal and cerebellar glutamate, γ-aminobutyric acid and dopamine levels: a microdialysis-electrocorticography study in freely moving rats. J Pharmacol Exp Ther 1997;283:123948.
  • 8
    Lindekens H, Smolders I, Khan GM, et al. In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy. Pharm Res 2000;17:140813.
  • 9
    Paxinos G, Watson C. The rat brain in stereotaxic coordinates. New York: Academic Press, 1996.
  • 10
    Racine RJ. Modification of seizure activity by electrical stimulation, II: motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:28193.